Fulcrum Therapeutics Inc. (FULC)
NASDAQ · Healthcare
Fulcrum Therapeutics Inc. Operating Income 2020–2025
Fulcrum Therapeutics Inc. annual/quarterly operating income history and growth rate from 2020 to 2025. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Fulcrum Therapeutics Inc. operating income for the quarter ending September 30, 2025 was -21.9 M, a 13.01% decrease year-over-year.
- Fulcrum Therapeutics Inc. operating income for the twelve months ending September 30, 2025 was -14.3 M, a 87.28% decrease year-over-year.
- Fulcrum Therapeutics Inc. annual operating income for 2025 was -84.8 M, a 287.13% increase from 2024.
- Fulcrum Therapeutics Inc. annual operating income for 2024 was -21.9 M, a 80.21% decrease from 2023.
- Fulcrum Therapeutics Inc. annual operating income for 2023 was -110.7 M, a 1.69% decrease from 2022.
- Fulcrum Therapeutics Inc. annual operating income for 2022 was -112.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Fulcrum Therapeutics Inc. Operating Income — FAQ
Fulcrum Therapeutics Inc. (FULC) operating income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Fulcrum Therapeutics Inc.'s operating income?
Fulcrum Therapeutics Inc. (FULC) reported operating income of -$85M for fiscal 2025.
Where can I see FULC's operating income history?
The chart and table above show Fulcrum Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.